Patent details

Basic Information

Publication number:

EP1802329

PCT Application Number:

PCT/EP/2005/055017

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP057920522

PCT Publication Number:

WO/2006/037789

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

A PHARMACEUTICAL FORMULATION COMPRISING CRYSTALLINE INSULIN AND DISSOLVED INSULIN

French Title of Invention:

FORMULATION PHARMACEUTIQUE COMPRENANT DE L'INSULINE CRISTALLISEE ET DE L'INSULINE EN SOLUTION

German Title of Invention:

PHARMAZEUTISCHE FORMULIERUNG MIT KRISTALLINEM INSULIN UND GELÖSTEM INSULIN

SPC Number:

Dates

Filing date:

05/10/2005

Grant date:

06/05/2015

EP Publication Date:

06/05/2015

PCT Publication Date:

13/04/2006

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

04/07/2007

EP B1 Publication Date:

06/05/2015

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

05/10/2015

Expiration date:

05/10/2025

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

05/10/2005

 

 

Name:

Novo Nordisk A/S

Address:

Novo Allé, 2880 Bagsværd, Denmark (DK)

Inventor

1

Name:

HAMMELEV Charlotte

Address:

Denmark (DK)

2

Name:

ESKILDSEN Lone

Address:

Denmark (DK)

3

Name:

BERGLUND Petter

Address:

Sweden (SE)

4

Name:

OLSEN Helle, Aalund

Address:

Denmark (DK)

5

Name:

KIMER Lone, Løgstrup

Address:

Denmark (DK)

6

Name:

MADSEN Johanne

Address:

Denmark (DK)

Priority

Priority Number:

200401519

Priority Date:

05/10/2004

Priority Country:

Denmark (DK)

Classification

Main IPC Class:

A61K 38/28;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages